If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Incontinence

Novel Drug for Overactive Bladder Works Even If Antimuscarinics Do Not

Jody A. Charnow February 29, 2012

PARIS—Mirabegron, an experimental drug for overactive bladder (OAB), can effectively treat the condition in patients whether or not they failed previous antimuscarinic therapy, according to findings presented at the 27th Annual Congress of the European Association of Urology.

Bulking Agent Injections Effective for Incontinence Salvage Therapy

Jody A. Charnow August 29, 2011

GLASGOW—Periurethral injections of polyacrylamid hydrogel (PAHG), a new bulking agent, are a safe and effective option as a salvage therapy for women with severe stress urinary incontinence (SUI) after failed previous surgical management, according to data presented at the International Continence Society annual meeting.

TOT Approach for SUI Effective

Jody A. Charnow April 01, 2010

The transobturator (TOT) approach from outside to inside is a highly effective treatment for stress urinary incontinence (SUI) in women, and it is associated with low morbidity, according to researchers in Saudi Arabia.

Preoperative Pelvic Floor Muscle Exercise May Improve Continence After Prostate Surgery

Jody A. Charnow March 17, 2010

Preoperative pelvic floor muscle exercise (PFME) may improve early continence and quality of life (QoL) outcomes after radical prostatectomy (RP) for localized prostate cancer, an Italian study found.

OAB Meds Not Equal When It Comes To Adverse Effects

Rosemary Frei, MSc October 22, 2009

Solifenacin-treated patients experienced less dry mouth than those taking oxybutynin immediate release.

Novel Botox Therapy May Work for Idiopathic Refractory OAB

Jody A. Charnow August 10, 2009

Researchers have reported encouraging results from a small study examining intravesical instillation of a botulinum toxin/dimethyl sulfoxide (DMSO) solution as a treatment for refractory idiopathic overactive bladder (OAB).